Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.

We tested the hypothesis that weight loss alleviates insulin resistance in skeletal muscle within the proximal steps of glucose metabolism, namely substrate delivery, glucose transport, and glucose phosphorylation. In obese subjects with and without type 2 diabetes, in vivo skeletal muscle assessments were obtained with dynamic positron emission tomography (PET) imaging performed during euglycemic clamps at moderate hyperinsulinemia (40 mU x min(-1) x m(-2)), using [(15)O]H(2)O and [(18)F]fluoro-deoxyglucose ([(18)F]FDG) to quantify tissue perfusion and glucose metabolism. Dynamic [(18)F]FDG PET data were analyzed using both a novel muscle-specific compartmental model and a compartmental model originally developed for the brain and often used for [(18)F]FDG muscle image quantification. Weight loss in obese subjects with (n = 9) and without (n = 9) type 2 diabetes over a 4-month intervention was substantial (14 +/- 2 kg, P < 0.05). Muscle insulin resistance, assessed by insulin-stimulated [(18)F]FDG uptake, decreased threefold in diabetic subjects and twofold in nondiabetic subjects (P < 0.001). Kinetic parameters for [(18)F]FDG transport and phosphorylation improved substantially in both groups, whereas tissue blood flow did not change. In particular, clinically significant weight loss fully corrected insulin resistance in type 2 diabetes at the step of glucose phosphorylation and largely, but incompletely, corrected insulin resistance at the glucose transport step.

[1]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[2]  G. Shulman,et al.  13C and 31P NMR Studies on the Effects of Increased Plasma Free Fatty Acids on Intramuscular Glucose Metabolism in the Awake Rat* , 1997, The Journal of Biological Chemistry.

[3]  R M Peshock,et al.  Relationship of Generalized and Regional Adiposity to Insulin Sensitivity in Men With NIDDM , 1996, Diabetes.

[4]  M. G. Carlson,et al.  Impact of Obesity on Insulin Action in NIDDM , 1993, Diabetes.

[5]  C Cobelli,et al.  Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. , 1996, Diabetes.

[6]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[7]  R R Wing,et al.  Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. , 1999, Diabetes.

[8]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[10]  D L Rothman,et al.  Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. , 1996, The New England journal of medicine.

[11]  C Cobelli,et al.  Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. , 2001, American journal of physiology. Endocrinology and metabolism.

[12]  B. Ludvik,et al.  Effect of Obesity on Insulin Resistance in Normal Subjects and Patients With NIDDM , 1995, Diabetes.

[13]  Roberto Vettor,et al.  Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. , 2002, Diabetes.

[14]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.

[15]  Eric Walter,et al.  Identification of Parametric Models: from Experimental Data , 1997 .

[16]  Arshag D Mooradian,et al.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.

[17]  J. Price,et al.  Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography. , 2001, Diabetes.

[18]  E. Hoffman,et al.  TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.

[19]  K. Petersen,et al.  13C/31P NMR studies on the mechanism of insulin resistance in obesity. , 1998, Diabetes.

[20]  H. Herzog,et al.  Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[22]  J. Price,et al.  Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET. , 1999, American journal of physiology. Endocrinology and metabolism.

[23]  J. Price,et al.  Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. , 2001, The Journal of clinical endocrinology and metabolism.

[24]  Claudio Cobelli,et al.  Minimal model SGoverestimation and SIunderestimation: improved accuracy by a Bayesian two-compartment model. , 1999, American journal of physiology. Endocrinology and metabolism.

[25]  H. Sipilä,et al.  Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans: studies using [15O]O2, [15O]H2O, [18F]fluoro-deoxy-glucose, and positron emission tomography. , 2000, Diabetes.

[26]  V. Oikonen,et al.  Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin-resistant skeletal muscle of patients with type 1 diabetes. , 2001, Diabetes.

[27]  C Cobelli,et al.  Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. , 1999, The American journal of physiology.

[28]  J. Friedman,et al.  Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. , 1992, The Journal of clinical investigation.

[29]  R. Wing,et al.  Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. , 1993, The Journal of clinical endocrinology and metabolism.

[30]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Kety.  The theory and applications of the exchange of inert gas at the lungs and tissues. , 1951, Pharmacological reviews.

[32]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[33]  Rena R Wing,et al.  Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.

[34]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[35]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[36]  C. Cobelli,et al.  Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. , 2003, The Journal of clinical endocrinology and metabolism.